Study shows new imaging technique accurately detects aggressive kidney cancer: Los Angeles, California Monday, October 7, 2024, 18:00 Hrs [IST] A new study led by investigators fr ...

The Nobel Prize in Physiology or Medicine for the year 2024 has been awarded to two US-based scientists Victor Ambros and ...

Exact Sciences’ next generation multitarget stool DNA test, Cologuard Plus test receives US FDA approval: Madison, Wisconsin Monday, October 7, 2024, 17:00 Hrs [IST] Exact Scien ...

A new study published in the American Society for Microbiology journal Microbiology Spectrum demonstrates that a novel semi-synthetic compound can be derived from natural compounds to produce potent ...

Joint action by Gujarat ATS, NCB, seizes Rs. 1,800 crore worth of drugs from Bhopal: Our Bureau, New Delhi Monday, October 7, 2024, 15:30 Hrs [IST] A joint action by Gujarat Anti- ...

USPTO grants patent to AIM ImmunoTech’s Ampligen for endometriosis treatment: Ocala, Florida Monday, October 7, 2024, 15:00 Hrs [IST] AIM ImmunoTech Inc. announced that the Unit ...

WHO prequalifies human papillomavirus vaccine, Cecolin for single-dose use: Geneva Monday, October 7, 2024, 14:00 Hrs [IST] WHO announced that a fourth WHO-prequalified human papi ...

India’s pharmaceutical supply chain is amongst the most complex supply networks. This is because a big company can operate at the national level with 8,000-10,000 distributors who individually sell ...

The Drugs Consultative Committee (DCC) has suggested that the cosmetics industry shall follow the standards set by the Bureau of Indian Standards (BIS) related to the ingredients, as it is not ...

The 27th ISP & International Conference held on 4 & 5, 2024, with the theme as “The Role of Traditional Medicine and Phytopharmaceuticals in Healthcare for Viksit Bharat," was successfully held at ...

GigaGen awarded US BARDA contract valued upto $135.2 mn to develop recombinant polyclonal antibody therapies for BoNT and an additional biothreat: San Carlos, California Monday, O ...

TiumBio begins patient dosing in phase 2 trial of oral immuno-oncology drug TU2218: Republic of Korea Monday, October 7, 2024, 12:00 Hrs [IST] TiumBio Co., Ltd., a clinical-stage ...